• Agenda
    • Get Involved
    • Attendee FAQs
    • Programs
    • In-Person Group Discussions
    • Short Courses
    • Plenary Keynotes
    • Speaker Biographies
    • Attendees
    • Networking
    • Archives
  • Sponsor/Exhibitor
    • Attendee Demographics + Event Features
    • Sponsorship Opportunities
    • Current Sponsors
    • Current Exhibitors - Floorplan
    • Re-sign Floorplan
    • Exhibit Services Schedule
    • Exhibitor Prospectus
    • Lead Generation Opportunities
    • FAQs
    • Sponsor & Exhibitor Portal
  • Media
    • Media Partners
    • Downloads
    • Media Gallery
  • Travel
  • Posters
    • Poster Information
    • Poster Titles
  • Register
    • Individual Pricing
    • Group Pricing
    • On Demand Pricing
Discovery on Target Mobile

Archives

  • Discovery on Target - October 17-20, 2022
  • Discovery on Target - September 27-30, 2021
  • Discovery on Target - September 15-18, 2020
  • Discovery on Target - September 16-19, 2019
  • Discovery on Target - September 25-28, 2018
  • Discovery on Target - September 25-29, 2017
  • Discovery on Target - September 19-22, 2016
  • Discovery on Target - September 21-24, 2015
  • Discovery on Target - October 8-10, 2014
  • Discovery on Target - September 24-26, 2013
  • Discovery on Target - October 1-3, 2012
  • Discovery on Target - November 2-4, 2011
  • Discovery on Target - November 2-4, 2010
  • Discovery on Target - November 2-4, 2009

 

 
 

 
 

 
 

 
 


Outlook YouTube Facebook LinkedIn Twitter
#BostonDOT23

Submit a Speaker Proposal
Register Early for Maximum Savings
Stay up to Date on our 2023 Program
2023 Programs
Download Brochure
View All Sponsors
View Media Partners

September 25

Emerging Immune Modulation Strategies

Strategies for Targeting Kinases

September 26-27

Protein Degraders and Molecular Glues – Part 1

Proteomics-Driven Drug Discovery

Small Molecules Targeting RNA

Small Molecules for Cancer Targets – Part 1

Neurodegeneration Targets

GPCR-Based Drug Discovery

Antibodies Against Membrane Protein Targets – Part 1

AI/ML-Enabled Drug Discovery – Part 1

September 27-28

Protein Degraders and Molecular Glues – Part 2

Genomics-Driven Drug Discovery

Targeting Transcription Factors

Small Molecules for Cancer Targets – Part 2

Fibrosis and Inflammation

Lead Generation Strategies

Antibodies Against Membrane Protein Targets – Part 2

AI/ML-Enabled Drug Discovery – Part 2

CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Investing and Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy